(MCI) Barings Corporate Investors - Ratings and Ratios
Corporate Debt, Investment Grade Securities, Common Stocks
MCI EPS (Earnings per Share)
MCI Revenue
Description: MCI Barings Corporate Investors
Barings Corporate Investors (NYSE:MCI) is a closed-end fund managed by Barings LLC, investing in the US fixed income market with a focus on below-investment grade corporate debt obligations across diversified sectors. The fund also invests in investment-grade debt securities, other debt securities, and common stocks.
Key performance indicators (KPIs) for MCI include a dividend yield, which is an essential metric for income-focused investors. As a closed-end fund, MCIs ability to distribute income to shareholders is crucial. Additionally, the funds net asset value (NAV) and its premium/discount to NAV are vital in assessing its market valuation. A consistent premium or discount may indicate market sentiment towards the funds management and investment strategy.
From a financial perspective, MCIs return on equity (RoE) of 10.26% indicates a decent return for shareholders. However, investors should also consider the funds expense ratio, which can erode returns. Furthermore, the funds investment portfolio composition, including the proportion of below-investment grade debt, is crucial in assessing its risk profile.
To further evaluate MCIs performance, investors can analyze its historical distribution coverage, which indicates the funds ability to cover its dividend payments from net investment income. Moreover, the funds leverage ratio, which measures its use of borrowed funds to amplify returns, is another essential metric to monitor, as excessive leverage can increase the risk of significant losses.
MCI Stock Overview
| Market Cap in USD | 442m |
| Sub-Industry | Asset Management & Custody Banks |
| IPO / Inception | 1985-07-01 |
MCI Stock Ratings
| Growth Rating | 86.9% |
| Fundamental | 75.0% |
| Dividend Rating | 95.8% |
| Return 12m vs S&P 500 | 11.8% |
| Analyst Rating | - |
MCI Dividends
| Dividend Yield 12m | 8.20% |
| Yield on Cost 5y | 19.32% |
| Annual Growth 5y | 11.98% |
| Payout Consistency | 93.6% |
| Payout Ratio | 1.9% |
MCI Growth Ratios
| Growth Correlation 3m | 17.4% |
| Growth Correlation 12m | 75.4% |
| Growth Correlation 5y | 91.3% |
| CAGR 5y | 20.01% |
| CAGR/Max DD 5y | 0.82 |
| Sharpe Ratio 12m | 2.04 |
| Alpha | 24.78 |
| Beta | 0.192 |
| Volatility | 19.04% |
| Current Volume | 19.3k |
| Average Volume 20d | 22.6k |
| Stop Loss | 21.1 (-3.4%) |
| Signal | 0.00 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (35.6m TTM) > 0 and > 6% of Revenue (6% = 2.60m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.19% (prev 32.72%; Δ -7.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 28.1m <= Net Income 35.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.67 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (20.4m) change vs 12m ago 0.70% (target <= -2.0% for YES) |
| Gross Margin 96.80% (prev 96.76%; Δ 0.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 10.82% (prev 10.46%; Δ 0.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 20.39 (EBITDA TTM -1.20m / Interest Expense TTM 1.78m) >= 6 (WARN >= 3) |
Altman Z'' 2.24
| (A) 0.03 = (Total Current Assets 27.3m - Total Current Liabilities 16.4m) / Total Assets 406.2m |
| (B) 0.11 = Retained Earnings (Balance) 44.7m / Total Assets 406.2m |
| (C) 0.09 = EBIT TTM 36.3m / Avg Total Assets 400.1m |
| (D) 1.04 = Book Value of Equity 65.1m / Total Liabilities 62.7m |
| Total Rating: 2.24 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 74.98
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 5.78% = 2.89 |
| 3. FCF Margin 65.00% = 7.50 |
| 4. Debt/Equity 0.18 = 2.48 |
| 5. Debt/Ebitda -52.19 = -2.50 |
| 6. ROIC - WACC 2.97% = 3.71 |
| 7. RoE 10.26% = 0.85 |
| 8. Rev. Trend 87.94% = 4.40 |
| 9. Rev. CAGR 26.05% = 2.50 |
| 10. EPS Trend 65.81% = 1.65 |
| 11. EPS CAGR 46.92% = 2.50 |
What is the price of MCI shares?
Over the past week, the price has changed by +5.30%, over one month by +5.10%, over three months by +6.81% and over the past year by +30.78%.
Is Barings Corporate Investors a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MCI is around 25.59 USD . This means that MCI is currently undervalued and has a potential upside of +17.17% (Margin of Safety).
Is MCI a buy, sell or hold?
What are the forecasts/targets for the MCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 27.9 | 27.9% |
Last update: 2025-08-30 04:49
MCI Fundamental Data Overview
CCE Cash And Equivalents = 17.2m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 12.4343
P/S = 10.204
P/B = 1.2856
Beta = 0.343
Revenue TTM = 43.3m USD
EBIT TTM = 36.3m USD
EBITDA TTM = -1.20m USD
Long Term Debt = 46.3m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 16.4m USD (from totalCurrentLiabilities, last quarter)
Debt = 62.7m USD (Calculated: Short Term 16.4m + Long Term 46.3m)
Net Debt = 28.6m USD (from netDebt column, last quarter)
Enterprise Value = 487.2m USD (441.7m + Debt 62.7m - CCE 17.2m)
Interest Coverage Ratio = 20.39 (Ebit TTM 36.3m / Interest Expense TTM 1.78m)
FCF Yield = 5.78% (FCF TTM 28.1m / Enterprise Value 487.2m)
FCF Margin = 65.00% (FCF TTM 28.1m / Revenue TTM 43.3m)
Net Margin = 82.20% (Net Income TTM 35.6m / Revenue TTM 43.3m)
Gross Margin = 96.80% ((Revenue TTM 43.3m - Cost of Revenue TTM 1.39m) / Revenue TTM)
Tobins Q-Ratio = 7.48 (Enterprise Value 487.2m / Book Value Of Equity 65.1m)
Interest Expense / Debt = 2.84% (Interest Expense 1.78m / Debt 62.7m)
Taxrate = 2.60% (from yearly Income Tax Expense: 950.2k / 36.5m)
NOPAT = 35.4m (EBIT 36.3m * (1 - 2.60%))
Current Ratio = 1.67 (Total Current Assets 27.3m / Total Current Liabilities 16.4m)
Debt / Equity = 0.18 (Debt 62.7m / last Quarter total Stockholder Equity 343.6m)
Debt / EBITDA = -52.19 (Net Debt 28.6m / EBITDA -1.20m)
Debt / FCF = 2.23 (Debt 62.7m / FCF TTM 28.1m)
Total Stockholder Equity = 346.8m (last 4 quarters mean)
RoA = 8.76% (Net Income 35.6m, Total Assets 406.2m )
RoE = 10.26% (Net Income TTM 35.6m / Total Stockholder Equity 346.8m)
RoCE = 9.24% (Ebit 36.3m / (Equity 346.8m + L.T.Debt 46.3m))
RoIC = 9.20% (NOPAT 35.4m / Invested Capital 384.8m)
WACC = 6.23% (E(441.7m)/V(504.4m) * Re(6.72%)) + (D(62.7m)/V(504.4m) * Rd(2.84%) * (1-Tc(0.03)))
Shares Correlation 5-Years: 70.70 | Cagr: 0.18%
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈29.7m ; Y1≈36.6m ; Y5≈62.5m
Fair Price DCF = 52.37 (DCF Value 1.06b / Shares Outstanding 20.3m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 87.94 | Revenue CAGR: 26.05%
Rev Growth-of-Growth: -27.58
EPS Correlation: 65.81 | EPS CAGR: 46.92%
EPS Growth-of-Growth: -88.48
Additional Sources for MCI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle